ge • Search Results


86
Hologic Inc bmd
Bmd, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bmd/product/Hologic Inc
Average 86 stars, based on 1 article reviews
bmd - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Philips Healthcare ge systems
Ge Systems, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ge systems/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
ge systems - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Photonics Inc quantum optoelectronics research team
Quantum Optoelectronics Research Team, supplied by Photonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantum optoelectronics research team/product/Photonics Inc
Average 86 stars, based on 1 article reviews
quantum optoelectronics research team - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

93
Danaher Inc 3 2 30 size exclusion column
3 2 30 Size Exclusion Column, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3 2 30 size exclusion column/product/Danaher Inc
Average 93 stars, based on 1 article reviews
3 2 30 size exclusion column - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
Danaher Inc igg sepharose 6 fast flow beads
FIG. 4. Protein complex analysis by BN/SDS-PAGE (A) and size exclusion chromatography (B). A, protein complexes fractionated in the first dimension by BN-PAGE. In the second dimension, proteins were separated by SDS-PAGE, and gels were immunoblotted with the anti-CDKA;1 antiserum (1:5000). For CDKA;135S, 400 g of protein was analyzed from the total protein extract (panel 1) and the IgG-unbound fraction (panel 2), and 55 g was analyzed from the final calmodulin eluate (panel 3). Recombinant CDKA;1 and CDKA;1 fused to the complete TAP tag and the CBP tag are indicated as CDKA;1-TAP and CDKA;1-CBP, respectively. B, CDKA;1-TAP eluate (2 ml) fractionated on a Superdex 200 (300/10) size exclusion chromatography column. From each 500-l fraction, 25 l was assayed for kinase activity with histone H1 as a substrate (panel 1), and 10 l was analyzed for the presence of the bait protein by immunoblotting with an antiserum against CDKA;1 (1:5000) (panel 2). Arrowheads indicate the elution positions of marker proteins with their molecular masses (kDa). Std, standard.
Igg Sepharose 6 Fast Flow Beads, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg sepharose 6 fast flow beads/product/Danaher Inc
Average 96 stars, based on 1 article reviews
igg sepharose 6 fast flow beads - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

99
Danaher Inc protein g sepharose bead
FIG. 4. Protein complex analysis by BN/SDS-PAGE (A) and size exclusion chromatography (B). A, protein complexes fractionated in the first dimension by BN-PAGE. In the second dimension, proteins were separated by SDS-PAGE, and gels were immunoblotted with the anti-CDKA;1 antiserum (1:5000). For CDKA;135S, 400 g of protein was analyzed from the total protein extract (panel 1) and the IgG-unbound fraction (panel 2), and 55 g was analyzed from the final calmodulin eluate (panel 3). Recombinant CDKA;1 and CDKA;1 fused to the complete TAP tag and the CBP tag are indicated as CDKA;1-TAP and CDKA;1-CBP, respectively. B, CDKA;1-TAP eluate (2 ml) fractionated on a Superdex 200 (300/10) size exclusion chromatography column. From each 500-l fraction, 25 l was assayed for kinase activity with histone H1 as a substrate (panel 1), and 10 l was analyzed for the presence of the bait protein by immunoblotting with an antiserum against CDKA;1 (1:5000) (panel 2). Arrowheads indicate the elution positions of marker proteins with their molecular masses (kDa). Std, standard.
Protein G Sepharose Bead, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein g sepharose bead/product/Danaher Inc
Average 99 stars, based on 1 article reviews
protein g sepharose bead - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

96
Danaher Inc hrp conjugated streptavidin
Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by <t>streptavidin-HRP</t> (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.
Hrp Conjugated Streptavidin, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrp conjugated streptavidin/product/Danaher Inc
Average 96 stars, based on 1 article reviews
hrp conjugated streptavidin - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
Danaher Inc hyperfilm mp
Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by <t>streptavidin-HRP</t> (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.
Hyperfilm Mp, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hyperfilm mp/product/Danaher Inc
Average 96 stars, based on 1 article reviews
hyperfilm mp - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
Danaher Inc hiprep 16 60 sephacryl s 300
Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by <t>streptavidin-HRP</t> (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.
Hiprep 16 60 Sephacryl S 300, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hiprep 16 60 sephacryl s 300/product/Danaher Inc
Average 96 stars, based on 1 article reviews
hiprep 16 60 sephacryl s 300 - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

94
Danaher Inc blue sepharose 6 fast flow
Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by <t>streptavidin-HRP</t> (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.
Blue Sepharose 6 Fast Flow, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blue sepharose 6 fast flow/product/Danaher Inc
Average 94 stars, based on 1 article reviews
blue sepharose 6 fast flow - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

98
Danaher Inc nitrocellulose membrane
Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by <t>streptavidin-HRP</t> (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.
Nitrocellulose Membrane, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nitrocellulose membrane/product/Danaher Inc
Average 98 stars, based on 1 article reviews
nitrocellulose membrane - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

96
Danaher Inc mem
Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by <t>streptavidin-HRP</t> (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.
Mem, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mem/product/Danaher Inc
Average 96 stars, based on 1 article reviews
mem - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

Image Search Results


FIG. 4. Protein complex analysis by BN/SDS-PAGE (A) and size exclusion chromatography (B). A, protein complexes fractionated in the first dimension by BN-PAGE. In the second dimension, proteins were separated by SDS-PAGE, and gels were immunoblotted with the anti-CDKA;1 antiserum (1:5000). For CDKA;135S, 400 g of protein was analyzed from the total protein extract (panel 1) and the IgG-unbound fraction (panel 2), and 55 g was analyzed from the final calmodulin eluate (panel 3). Recombinant CDKA;1 and CDKA;1 fused to the complete TAP tag and the CBP tag are indicated as CDKA;1-TAP and CDKA;1-CBP, respectively. B, CDKA;1-TAP eluate (2 ml) fractionated on a Superdex 200 (300/10) size exclusion chromatography column. From each 500-l fraction, 25 l was assayed for kinase activity with histone H1 as a substrate (panel 1), and 10 l was analyzed for the presence of the bait protein by immunoblotting with an antiserum against CDKA;1 (1:5000) (panel 2). Arrowheads indicate the elution positions of marker proteins with their molecular masses (kDa). Std, standard.

Journal: Molecular & Cellular Proteomics

Article Title: A Tandem Affinity Purification-based Technology Platform to Study the Cell Cycle Interactome in Arabidopsis thaliana

doi: 10.1074/mcp.m700078-mcp200

Figure Lengend Snippet: FIG. 4. Protein complex analysis by BN/SDS-PAGE (A) and size exclusion chromatography (B). A, protein complexes fractionated in the first dimension by BN-PAGE. In the second dimension, proteins were separated by SDS-PAGE, and gels were immunoblotted with the anti-CDKA;1 antiserum (1:5000). For CDKA;135S, 400 g of protein was analyzed from the total protein extract (panel 1) and the IgG-unbound fraction (panel 2), and 55 g was analyzed from the final calmodulin eluate (panel 3). Recombinant CDKA;1 and CDKA;1 fused to the complete TAP tag and the CBP tag are indicated as CDKA;1-TAP and CDKA;1-CBP, respectively. B, CDKA;1-TAP eluate (2 ml) fractionated on a Superdex 200 (300/10) size exclusion chromatography column. From each 500-l fraction, 25 l was assayed for kinase activity with histone H1 as a substrate (panel 1), and 10 l was analyzed for the presence of the bait protein by immunoblotting with an antiserum against CDKA;1 (1:5000) (panel 2). Arrowheads indicate the elution positions of marker proteins with their molecular masses (kDa). Std, standard.

Article Snippet: Briefly total protein extract was incubated for 1 h at 4 °C under gentle rotation with 500 l of IgG-Sepharose 6 Fast Flow beads (GE Healthcare) pre-equilibrated with 10 ml of extraction buffer.

Techniques: SDS Page, Size-exclusion Chromatography, Recombinant, Activity Assay, Western Blot, Marker

Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by streptavidin-HRP (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.

Journal: Journal of thrombosis and haemostasis : JTH

Article Title: The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

doi: 10.1111/jth.13208

Figure Lengend Snippet: Fig. 4. Panels A–E: binding of LP components from serially diluted lepirudin-PPP (starting with 3% dilution) to plasmin-generated fragments of fibrinogen and fibrin coating microtiter plates. Detection was carried out using specific biotinylated mAbs followed by streptavidin-HRP (n = 3). Panel A: negligible binding of MBL, Ficolin-1, Ficolin-2 and Ficolin-3 to fibrin fragment DD. Panel B: significant binding of MASP-1 and, to a lesser degree, MASP-2 to fibrin fragment DD. Insignificant binding of MASP-1 and MASP-2 to fibrin fragment E (panel C), fibrino- gen fragment D (panel D) and fibrinogen fragment E (panel E). Panels F–G: generation of MASP-1 and MASP-2/AT complexes by fibrin and fibrin fragment DD. Lepirudin-PPP (n = 3) was incubated with increasing concentrations of fibrin (0–12 lg mL1, panel F) or fibrin fragment DD (0–25 lg mL1, panel G). After incubation MASP-1 and MASP-2/AT/C1-INH complexes were quantified by sandwich ELISA. In PPP in contact with fibrin, MASP-1/AT and MASP-2/AT complexes were preferentially formed (panel F). Fibrin fragment DD induced similar genera- tion of both MASP-1, MASP-2/AT and MASP-1 and MASP-2/C1-INH, but the latter were formed at a much lower concentration of DD (panel G). LP, lectin pathway; PPP, platelet-poor plasma; MBL, mannose-binding lectin; AT, antithrombin.

Article Snippet: 4 The wells were then incubated with 60 lL of HRP-conjugated streptavidin (GE Healthcare) diluted 1 : 500.

Techniques: Binding Assay, Generated, Incubation, Sandwich ELISA, Concentration Assay, Clinical Proteomics